Sangamo Therapeutics Inc (SGMO)
0.4997
+0.01
(+2.97%)
USD |
NASDAQ |
Apr 19, 15:19
Sangamo Therapeutics Profit Margin (Quarterly): -2.95K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.95K% |
| September 30, 2023 | -1.11K% |
| June 30, 2023 | -1.68K% |
| March 31, 2023 | 13.38% |
| December 31, 2022 | -190.9% |
| September 30, 2022 | -200.9% |
| June 30, 2022 | -147.0% |
| March 31, 2022 | -155.8% |
| December 31, 2021 | -134.0% |
| September 30, 2021 | -167.0% |
| June 30, 2021 | -169.2% |
| March 31, 2021 | -174.8% |
| December 31, 2020 | -157.4% |
| September 30, 2020 | -2.68% |
| June 30, 2020 | -166.7% |
| March 31, 2020 | -328.2% |
| December 31, 2019 | 8.30% |
| September 30, 2019 | -124.4% |
| June 30, 2019 | -172.6% |
| March 31, 2019 | -522.2% |
| December 31, 2018 | -69.55% |
| September 30, 2018 | -54.51% |
| June 30, 2018 | -77.70% |
| March 31, 2018 | -159.7% |
| December 31, 2017 | -100.1% |
| Date | Value |
|---|---|
| September 30, 2017 | -104.6% |
| June 30, 2017 | -151.4% |
| March 31, 2017 | -485.6% |
| December 31, 2016 | -107.9% |
| September 30, 2016 | -671.8% |
| June 30, 2016 | -717.9% |
| March 31, 2016 | -418.4% |
| December 31, 2015 | -153.6% |
| September 30, 2015 | -107.9% |
| June 30, 2015 | -145.1% |
| March 31, 2015 | -39.43% |
| December 31, 2014 | -28.89% |
| September 30, 2014 | -60.76% |
| June 30, 2014 | -67.22% |
| March 31, 2014 | -93.30% |
| December 31, 2013 | -118.6% |
| September 30, 2013 | -107.7% |
| June 30, 2013 | -78.60% |
| March 31, 2013 | -148.9% |
| December 31, 2012 | -38.94% |
| September 30, 2012 | -118.0% |
| June 30, 2012 | -125.2% |
| March 31, 2012 | -224.2% |
| December 31, 2011 | -133.9% |
| September 30, 2011 | -514.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.95K%
Minimum
Dec 2023
13.38%
Maximum
Mar 2023
-421.4%
Average
-167.0%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -57.64% |
| Electromed Inc | 12.23% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -119.1% |
| Return on Assets | -75.25% |
| Return on Invested Capital | -119.1% |
| Operating Margin (Quarterly) | -3.02K% |
| Return on Net Operating Assets | -211.5% |